Kalil Andre C, Metersky Mark L, Klompas Michael, Muscedere John, Sweeney Daniel A, Palmer Lucy B, Napolitano Lena M, O'Grady Naomi P, Bartlett John G, Carratalà Jordi, El Solh Ali A, Ewig Santiago, Fey Paul D, File Thomas M, Restrepo Marcos I, Roberts Jason A, Waterer Grant W, Cruse Peggy, Knight Shandra L, Brozek Jan L
Department of Internal Medicine, Division of Infectious Diseases, University of Nebraska Medical Center, Omaha.
Division of Pulmonary and Critical Care Medicine, University of Connecticut School of Medicine, Farmington.
Clin Infect Dis. 2016 Sep 1;63(5):e61-e111. doi: 10.1093/cid/ciw353. Epub 2016 Jul 14.
It is important to realize that guidelines cannot always account for individual variation among patients. They are not intended to supplant physician judgment with respect to particular patients or special clinical situations. IDSA considers adherence to these guidelines to be voluntary, with the ultimate determination regarding their application to be made by the physician in the light of each patient's individual circumstances.These guidelines are intended for use by healthcare professionals who care for patients at risk for hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP), including specialists in infectious diseases, pulmonary diseases, critical care, and surgeons, anesthesiologists, hospitalists, and any clinicians and healthcare providers caring for hospitalized patients with nosocomial pneumonia. The panel's recommendations for the diagnosis and treatment of HAP and VAP are based upon evidence derived from topic-specific systematic literature reviews.
重要的是要认识到，指南不可能总是考虑到患者之间的个体差异。它们并非旨在取代医生针对特定患者或特殊临床情况的判断。美国感染病学会认为遵守这些指南是自愿的，医生应根据每个患者的具体情况对其应用做出最终决定。这些指南供照顾有医院获得性肺炎（HAP）和呼吸机相关性肺炎（VAP）风险患者的医疗保健专业人员使用，包括传染病、肺病、重症监护领域的专家以及外科医生、麻醉师、住院医师，以及任何照顾患有医院内肺炎住院患者的临床医生和医疗保健提供者。该小组对HAP和VAP的诊断和治疗建议基于针对特定主题的系统文献综述得出的证据。
